 |
| Hubungi kami |
|
| PT sanofi-aventis Indonesia |
Jl. Jend. A. Yani, Pulo Mas
Jakarta 13210
Indonesia
Tel.: +62 (21) 478 99 789
Fax: +62 (21) 475 4321
+62 (21) 475 4324
PT Aventis Pharma
Jl. Jend. A. Yani, Pulo Mas
Jakarta 13210
Indonesia
Tel.: +62 (21) 489 2208
+62 (21) 489 5608
Fax: +62 (21) 475 1035
sanofi-pasteur
Divisi dari PT Aventis Pharma
Jl. Jend. A. Yani, Pulo Mas
Jakarta 13210
Indonesia
Tel.: +62 (21) 478 99 763
Fax: +62 (21) 478 62 018
|
| Klik di sini |
|
|
|
|
 | Ruang Pers |
|
 | Siaran Pers Ditujukan untuk Jurnalis, Analis, and Investor. |
|
|
|
| Berita terkini |
|
| Agustus 30, 2010 |
| Teriflunomide Significantly Reduced Annualized Relapse Rate and was well Tolerated in MS patients |
| First results from the TEMSO phase III trial to be presented during the ECTRIMS congress in October 2010
|
|
|
| Agustus 26, 2010 |
| Sanofi-aventis Comments on Injunctive Relief Hearing Regarding Lovenox® |
|
|
|
|
| Juli 27, 2010 |
| Sanofi-aventis and Merck appoint Raul Kohan as CEO for the new Animal Health joint venture |
| Proposed JV to be called Merial-Intervet
|
|
|
|
 |
|
Corporate Information
Ruang Pers Korporasi
|
|
|
 |
|
